The pimped numbers confirm that there is simply no investment in R&D. This leaves a fragile 500 patient leg and a full bank account. Stock market evaluates the future. Without diversification and new products, all that remains is the bank account.
Countdown to implosion: 8 days.
- Forums
- ASX - By Stock
- CUV
- Ann: Appendix 4D and Half Year Report
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.00%
!
$9.76

Ann: Appendix 4D and Half Year Report, page-35
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.76 |
Change
0.000(0.00%) |
Mkt cap ! $489.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 501 | $10.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.50 | 521 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 501 | 10.530 |
1 | 329 | 10.000 |
3 | 2510 | 9.800 |
1 | 370 | 9.750 |
1 | 4 | 9.710 |
Price($) | Vol. | No. |
---|---|---|
9.610 | 901 | 1 |
9.650 | 110 | 1 |
9.700 | 3000 | 1 |
9.800 | 3 | 1 |
9.890 | 351 | 1 |
Last trade - 09.42am 18/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
Day chart unavailable
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online